AUA2023: Refractory Overactive Bladder: How To Select 3rd Line Therapies and Optimize Outcomes

CME Available: https://auau.auanet.org/node/38287
CME Expiration Date: May, 2024

ACKNOWLEDGEMENTS
Independent educational grant support provided by:
Astellas
Urovant Sciences, Inc.